Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
CONCLUSION
Emitents Rīgas farmaceitiskā fabrika, AS
Veids Citi
Valoda EN
Statuss Publicēts
Versija
Datums 2015-07-15 12:23:28
Versijas komentārs
Teksts

 JSC „RĪGAS FARMACEITISKĀ FABRIKA” board

Registration number 40003000765
Legal address: Duntes iela 16/22, Riga, LV-1005
 
 Riga, 14 July 2015
 
                                              CONCLUSION
                                         on compulsory and final stock redemption offer
 
On 7 July 2015 the Financial and capital market commission has resolved on permission to express JSC “RĪGAS FARMACEITISKĀ FABRIKA”, registration number 40001000765, compulsory and final stock redemption offer.
 
On 13 July 2015 information is published in the official journal “Latvijas Vēstnesis” according to the paragraph four of the Article 73 and the paragraph eight of the Article 82 of the Financial Instrument Market Law.
 
The redemption price of one share of JSC “RĪGAS FARMACEITISKĀ FABRIKA” is stated in the amount of EUR 1,56.
 
The board of JSC “RĪGAS FARMACEITISKĀ FABRIKA” has assessed the compulsory and final stock redemption offer of LLC “CAPITAL HOLDING” and admits the offer; it is under laws and regulations.
 
LLC „CAPITAL HOLDING” has acquired 95,66 % of JSC “RĪGAS FARMACEITIKSĀ FABRIKA” shares and has voted “for” exclusion of the shares from regulated market. The board of JSC “RĪGAS FARMACEITISKĀ FABRIKA” does not provide that there will be changes after the compulsory and final stock redemption offer, taking into account that this shareholder will continue the started activity of the company and concluded contracts of employment. Therefore JSC “RĪGAS FARMACEITISKĀ FABRIKA” will continue the commercial activity at the same place and extent.
 
 
JSC „RĪGAS FARMACEITISKĀ FABRIKA”
The Chairman of the board
Kaspars Balins
Pielikumi